Knight Therapeutics Inc. Announces Further Update on Extension of First Quarter 2020 Filings due to COVID-19 Toronto Stock Exchange:GUD
MONTREAL, May 29, 2020 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (TSX:GUD) (“Knight” or the “Company”), a leading pan-American (ex USA) specialty pharmaceutical company, announced today,...

